Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
De novo lupus nephritis during treatment with belimumab.
Parodis I, Vital EM, Hassan SU, Jönsen A, Bengtsson AA, Eriksson P, Leonard D, Gunnarsson I, Rönnblom L, Sjöwall C. Parodis I, et al. Rheumatology (Oxford). 2021 Sep 1;60(9):4348-4354. doi: 10.1093/rheumatology/keaa796. Rheumatology (Oxford). 2021. PMID: 33341888 Free PMC article.
Clinical trial outcomes for SLE: what we have and what we need.
Arnaud L, Parodis I, Devilliers H, Chasset F. Arnaud L, et al. Among authors: parodis i. Lupus Sci Med. 2024 Feb 15;11(1):e001114. doi: 10.1136/lupus-2023-001114. Lupus Sci Med. 2024. PMID: 38360028 Free PMC article. Review.
Biologics in SLE: towards new approaches.
van Vollenhoven RF, Parodis I, Levitsky A. van Vollenhoven RF, et al. Among authors: parodis i. Best Pract Res Clin Rheumatol. 2013 Jun;27(3):341-9. doi: 10.1016/j.berh.2013.07.006. Best Pract Res Clin Rheumatol. 2013. PMID: 24238691 Review.
Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy.
Parodis I, Zickert A, Sundelin B, Axelsson M, Gerhardsson J, Svenungsson E, Malmström V, Gunnarsson I. Parodis I, et al. Lupus Sci Med. 2015 Jan 22;2(1):e000061. doi: 10.1136/lupus-2014-000061. eCollection 2015. Lupus Sci Med. 2015. PMID: 25632350 Free PMC article.
Antiphospholipid Antibodies in Lupus Nephritis.
Parodis I, Arnaud L, Gerhardsson J, Zickert A, Sundelin B, Malmström V, Svenungsson E, Gunnarsson I. Parodis I, et al. PLoS One. 2016 Jun 23;11(6):e0158076. doi: 10.1371/journal.pone.0158076. eCollection 2016. PLoS One. 2016. PMID: 27336701 Free PMC article.
Interferon (IFN)-λ is a potential mediator in lupus nephritis.
Zickert A, Oke V, Parodis I, Svenungsson E, Sundström Y, Gunnarsson I. Zickert A, et al. Among authors: parodis i. Lupus Sci Med. 2016 Nov 22;3(1):e000170. doi: 10.1136/lupus-2016-000170. eCollection 2016. Lupus Sci Med. 2016. PMID: 27933198 Free PMC article.
150 results